Cargando…

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection

Detalles Bibliográficos
Autores principales:	Sahay, Sandeep, Farber, Harrison W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297206/ https://www.ncbi.nlm.nih.gov/pubmed/32595934 http://dx.doi.org/10.1177/2045894020933480

Ejemplares similares

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review
por: Wesley Milks, Michael, et al.
Publicado: (2021)

Pulmonary hypertension secondary to takayasu’s arteritis: management using a combined medical and interventional approach
por: Nitzberg, Matthew, et al.
Publicado: (2020)

Response to “Noninvasive determinants of pulmonary hypertension (PH) in interstitial lung disease (ILD)” by Joseph et al.
por: Parikh, Raj, et al.
Publicado: (2023)

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?
por: Piccari, Lucilla, et al.
Publicado: (2021)

Pulmonary artery thrombosis in COVID-19 patients
por: Graziani, A., et al.
Publicado: (2021)

Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”
por: Fernandes, Timothy M., et al.
Publicado: (2020)

Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2020)

Management of hypertension in COVID-19
por: Antwi-Amoabeng, Daniel, et al.
Publicado: (2020)

Overdue to understand anticoagulation in pulmonary arterial hypertension
por: Parikh, Kishan S., et al.
Publicado: (2018)

Pulmonary arterial hypertension incidence in Latvia in 2019
por: Kaulins, Ricards, et al.
Publicado: (2022)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

An adult case of NOTCH3 mutation in pulmonary artery hypertension
por: Padhye, Akhilesh A., et al.
Publicado: (2022)

Insights and Advances in the Diagnosis, Treatment, and Management of Pulmonary Hypertension
por: Guha, Ashrith, et al.
Publicado: (2021)

What is the psychosocial burden of COVID‐19 on people with pulmonary hypertension?
por: Rawlings, Gregg H., et al.
Publicado: (2022)

Pulmonary embolism detected by CT pulmonary angiography in hospitalized COVID-19 patients
por: Bunel, V., et al.
Publicado: (2021)

Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?’”
por: Horn, Evelyn, et al.
Publicado: (2020)

Letter to the Editor concerning: pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19
por: Lozano-Carrillo, Luis Carlos, et al.
Publicado: (2021)

Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
por: Umoru, Godsfavour, et al.
Publicado: (2020)

Differences in clinical and lab characteristics between adults and children hospitalized with COVID-19 infection over a 2-month period at a tertiary COVID care center: A cross-sectional study
por: Rai, Deependra Kumar, et al.
Publicado: (2021)

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
por: Chebib, Nader, et al.
Publicado: (2017)

Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension
por: Kalemci, Serdar, et al.
Publicado: (2019)

Palliative care in pulmonary arterial hypertension: an underutilised treatment
por: Khirfan, Ghaleb, et al.
Publicado: (2018)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Preoperative pulmonary artery hypertension as a risk factor: the tip of the iceberg
por: Engin, Mesut, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022)

Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
por: Hassoun, Paul M., et al.
Publicado: (2021)

Ameliorated nailfold capillary morphology of patients with pulmonary arterial hypertension in systemic sclerosis, treated with riociguat
por: Sugimoto, Tomohiro, et al.
Publicado: (2023)

Understanding the perspective of patients with pulmonary arterial hypertension: looking beyond health-related quality of life
por: Aguirre-Camacho, Aldo
Publicado: (2021)

Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
por: Farmakis, Ioannis T., et al.
Publicado: (2023)

Prone positioning in management of COVID-19 hospitalized patients
por: Moghadam, Vahid Damanpak, et al.
Publicado: (2020)

Pulmonary venous thrombosis in a patient with COVID-19 infection
por: Pasha, Ahmed K., et al.
Publicado: (2021)

Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
por: Kayarat, Bhavana, et al.
Publicado: (2021)

Acute pulmonary embolism: An unseen villain in COVID-19
por: Agstam, Sourabh, et al.
Publicado: (2020)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
por: Ahn, Kyung Jin, et al.
Publicado: (2019)

Re; Dilemma in the management of disconnected pulmonary arteries with double arterial ducts
por: Kothari, Shyam Sunder
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ke1ihnhsnf058dvolb3j3gf9q5